Volume 21 Issue 8
Aug.  2023
Turn off MathJax
Article Contents
ZHU Yiyi, YU Ruiqi, YUAN Tao, ZHANG Huabing, WANG Xi, WANG Linjie, WU Xueyan. Hyperandrogenism in postmenopausal women: a case report and literature review[J]. Chinese Journal of General Practice, 2023, 21(8): 1444-1448. doi: 10.16766/j.cnki.issn.1674-4152.003142
Citation: ZHU Yiyi, YU Ruiqi, YUAN Tao, ZHANG Huabing, WANG Xi, WANG Linjie, WU Xueyan. Hyperandrogenism in postmenopausal women: a case report and literature review[J]. Chinese Journal of General Practice, 2023, 21(8): 1444-1448. doi: 10.16766/j.cnki.issn.1674-4152.003142

Hyperandrogenism in postmenopausal women: a case report and literature review

doi: 10.16766/j.cnki.issn.1674-4152.003142
Funds:

 2022-PUMCH-A-064

  • Received Date: 2022-11-22
    Available Online: 2023-09-13
  • A 71-year-old female complained of hirsutism, androgenetic alopecia and enlarged clitoris after 10 years of post-menopause. Laboratory examination of total testosterone level was elevated (1.55-1.79 ng/mL, reference range: 0.08-0.60 ng/mL), while dehydroepiandrosterone sulfate was within normal range. No obvious adrenal or ovarian mass was shown on imaging. Laparoscopy exploration was refused owing to advanced age and multiple comorbidities. After the 8-month trial of gonadotropin-releasing hormone analogue triptorelin, improved hirsutism and reduced androgenetic alopecia were observed, with decreased luteinizing hormone levels from 31 to 0.2 IU/L and normalized testosterone levels to 0.47 ng/mL. No signs of tumor metastasis or ovarian enlargement were found on imaging examination. At the same time, the combination of lifestyle intervention and lipid lowering treatment can improve patients ' metabolic abnormalities, alleviate psychological anxiety, and improve their quality of life.

     

  • loading
  • [1]
    CUSSEN L, MCDONNELL T, BENNETT G, et al. Approach to androgen excess in women: clinical and biochemical insights[J]. Clin Endocrinol (Oxf), 2022, 97(2): 174-186. doi: 10.1111/cen.14710
    [2]
    SHIFREN J L, DAVIS S R. Androgens in postmenopausal women: a review[J]. Menopause, 2017, 24(8): 970-979. doi: 10.1097/GME.0000000000000903
    [3]
    STANCZYK F Z, CHAIKITTISILPA S, SRIPRASERT I, et al. Circulating androgen levels before and after oophorectomy in premenopausal and postmenopausal women[J]. Climacteric, 2019, 22(2): 169-174. doi: 10.1080/13697137.2018.1535584
    [4]
    KANAKIS G A, TSAMETIS C P, GOULIS D G. Measuring testosterone in women and men [J]. Maturitas, 2019, 125: 41-44. doi: 10.1016/j.maturitas.2019.04.203
    [5]
    SHARMA A, KAPOOR E, SINGH R J, et al. Diagnostic thresholds for androgen-producing tumors or pathologic hyperandrogenism in women by use of total testosterone concentrations measured by liquid chromatography-tandem mass spectrometry[J]. Clin Chem, 2018, 64(11): 1636-1645. doi: 10.1373/clinchem.2018.290825
    [6]
    ELHASSAN Y S, IDKOWIAK J, SMITH K, et al. Causes, patterns, and severity of androgen excess in 1205 consecutively recruited women[J]. J Clin Endocrinol Metab, 2018, 103(3): 1214-1223. doi: 10.1210/jc.2017-02426
    [7]
    戴好, 卢琳, 邢小平, 等. 中剂量地塞米松雄激素抑制试验在女性高雄激素血症中的诊断价值[J]. 中华医学杂志, 2018, 98(26): 2073-2077. doi: 10.3760/cma.j.issn.0376-2491.2018.26.003

    DAI H, LU L, XING X P, et al. Efficacy of medium dose dexamethasone androgen suppression test in the diagnosis of female hyperandrogenism[J]. National Medical Journal of China, 2018, 98(26): 2073-2077. doi: 10.3760/cma.j.issn.0376-2491.2018.26.003
    [8]
    ZOU M, CHEN R, WANG Y H, et al. Clinical and ultrasound characteristics of virilizing ovarian tumors in pre- and postmenopausal patients: a single tertiary center experience[J]. Orphanet J Rare Dis, 2021, 16(1): 426. doi: 10.1186/s13023-021-02057-z
    [9]
    HICKMAN L C, GOODMAN L, FALCONE T. Value of selective venous catheterization in the diagnosis of hyperandrogenism[J]. Fertil Steril, 2017, 108(6): 1085. doi: 10.1016/j.fertnstert.2017.08.037
    [10]
    MAMOOJEE Y, GANGURI M, TAYLOR N, et al. Clinical case seminar: postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis [J]. Clin Endocrinol (Oxf), 2018, 88(1): 13-20. doi: 10.1111/cen.13492
    [11]
    BAHAELDEIN E, BRASSILL M J. Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women[J]. Endocrinol Diabetes Metab Case Rep, 2018, 2018: 18-0084. DOI: 10.1530/EDM-18-0084.
    [12]
    HIRSCHBERG A L. Approach to investigation of hyperandrogenism in a postmenopausal woman[J]. J Clin Endocrinol Metab, 2022: dgac673. DOI: 10.1210/clinem/dgac673.
    [13]
    王曦, 许建萍, 刘兆祥, 等. GnRH类似物治疗绝经后促性腺激素依赖性高雄激素血症持续缓解一例并文献复习[J]. 中华内分泌代谢杂志, 2018, 34(1): 53-56.

    WANG X, XU J P, LIU Z X, et al. Effective GnRH analogue treatment and persistent remission of postmenopausal gonadotropin dependent hyperandrogenism: one case report and literature review[J]. Chinese Journal of Endocrinology and Metabolism, 2018, 34(1): 53-56.
    [14]
    万惠卿, 蔡玉群, 李薇, 等. 女性血清睾酮水平及年龄与代谢综合征的关系[J]. 中华全科医学, 2016, 14(2): 251-253. doi: 10.16766/j.cnki.issn.1674-4152.2016.02.030

    WAN H Q, CAI Y Q, LI W, et al. Correlation between serum testosterone and age with metabolic syndrome in women[J]. Chinese Journal of General Practice, 2016, 14(2): 251-253. doi: 10.16766/j.cnki.issn.1674-4152.2016.02.030
    [15]
    ZAMAN A, ROTHMAN M S. Postmenopausal hyperandrogenism: evaluation and treatment strategies[J]. Endocrinol Metab Clin North Am, 2022, 50(1): 97-111.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)  / Tables(1)

    Article Metrics

    Article views (342) PDF downloads(16) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return